AD and diabetes share common inflammatory signaling pathways, suggesting that mechanisms similar to those that mediate peripheral insulin resistance in type 2 diabetes may also underlie impaired brain insulin signaling and neuronal dysfunction in AD. The gene discussed is INS; the disease is Alzheimer disease.